Deutsche Bank AG bought a new position in shares of National HealthCare Corporation (NYSEAMERICAN:NHC - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 27,019 shares of the company's stock, valued at approximately $5,711,000. Deutsche Bank AG owned approximately 0.17% of National HealthCare at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Royal Bank of Canada increased its stake in shares of National HealthCare by 53.6% during the first quarter. Royal Bank of Canada now owns 2,724 shares of the company's stock worth $253,000 after buying an additional 950 shares during the period. AQR Capital Management LLC grew its holdings in National HealthCare by 1.7% during the 1st quarter. AQR Capital Management LLC now owns 16,080 shares of the company's stock worth $1,492,000 after acquiring an additional 262 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of National HealthCare by 3.1% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,247 shares of the company's stock valued at $858,000 after purchasing an additional 281 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of National HealthCare by 7.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 73,772 shares of the company's stock valued at $6,846,000 after purchasing an additional 4,879 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of National HealthCare by 18.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 30,246 shares of the company's stock valued at $2,807,000 after purchasing an additional 4,628 shares in the last quarter. 56.44% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
NHC has been the topic of several research analyst reports. Robert W. Baird upgraded shares of National HealthCare to a "strong-buy" rating in a research note on Monday, May 18th. The Goldman Sachs Group raised National HealthCare to a "strong-buy" rating in a report on Monday, May 18th. Royal Bank Of Canada raised National HealthCare to a "hold" rating in a research report on Monday, May 18th. Finally, BMO Capital Markets upgraded National HealthCare to a "hold" rating in a research note on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, National HealthCare currently has an average rating of "Buy".
Read Our Latest Stock Report on NHC
Insider Transactions at National HealthCare
In other National HealthCare news, Director Lisa Piercey bought 949 shares of National HealthCare stock in a transaction that occurred on Monday, June 1st. The shares were purchased at an average cost of $184.26 per share, for a total transaction of $174,862.74. Following the completion of the transaction, the director owned 949 shares of the company's stock, valued at $174,862.74. This represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Stephen Fowler Flatt sold 1,500 shares of the firm's stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $237.08, for a total transaction of $355,620.00. Following the completion of the sale, the chief executive officer directly owned 65,487 shares in the company, valued at $15,525,657.96. This represents a 2.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 13.92% of the company's stock.
National HealthCare Price Performance
National HealthCare stock opened at $228.38 on Tuesday. The stock's 50 day moving average price is $217.18 and its 200 day moving average price is $188.25. National HealthCare Corporation has a 1-year low of $110.83 and a 1-year high of $239.29. The company has a market cap of $3.58 billion, a PE ratio of 25.69 and a beta of 0.61.
National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $1.74 earnings per share for the quarter. The company had revenue of $408.03 million for the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%.
National HealthCare Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.67 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.2%. National HealthCare's dividend payout ratio (DPR) is presently 61.89%.
National HealthCare Profile
(
Free Report)
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider National HealthCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National HealthCare wasn't on the list.
While National HealthCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
